Work

A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML

Year: 2021

Type: article

Source: Blood Advances

DOI: 10.1182/bloodadvances.2020003685

Authors: Emily F. Mason, Olga Pozdnyakova, Mikhail Roshal, Amir T. Fathi, Eytan M. Stein, P. Brent Ferrell, Aaron C. Shaver, Mark Frattini, Hongfang Wang, Lei Hua, Jimmy Mu, Sung Choe, Rengyi Xu, Caroline Almon, Michael Cooper, Richard M. Stone, Robert P. Hasserjian, Michael R. Savona

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Brigham and Women's Hospital, Harvard University, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Celgene (United States), Agios Pharmaceuticals (United States), Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,800

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: Investigating the role of the JAK/STAT3 Pathway in Clonal Proliferation and Immune Dysfunction in Myelodysplastic Syndrome, Cancer Center Support Grant

OpenAlex ID: W3157859050

FWCI: 0.415

Cites: 12

Cited by: 7

Related to: 10